Cargando…
Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of the end of 2020, there were nearly 10 million confirmed cases and nearly 5 million deaths associated with COVID-19. Rapid and early labora...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329657/ https://www.ncbi.nlm.nih.gov/pubmed/32621814 http://dx.doi.org/10.1016/j.cca.2020.06.045 |
_version_ | 1783552942431797248 |
---|---|
author | Li, Chenxi Zhao, Chengxue Bao, Jingfeng Tang, Bo Wang, Yunfeng Gu, Bing |
author_facet | Li, Chenxi Zhao, Chengxue Bao, Jingfeng Tang, Bo Wang, Yunfeng Gu, Bing |
author_sort | Li, Chenxi |
collection | PubMed |
description | The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of the end of 2020, there were nearly 10 million confirmed cases and nearly 5 million deaths associated with COVID-19. Rapid and early laboratory diagnosis of COVID-19 is the main focus of treatment and control. Molecular tests are the basis for confirmation of COVID-19, but serological tests for SARS-CoV-2 are widely available and play an increasingly important role in understanding the epidemiology of the virus and in identifying populations at higher risk for infection. Point-of-care tests have the advantage of rapid, accurate, portable, low cost and non-specific device requirements, which provide great help for disease diagnosis and detection. This review will discuss the performance of different laboratory diagnostic tests and platforms, as well as suitable clinical samples for testing, and related biosafety protection. This review shall guide for the diagnosis of COVID-19 caused by SARS-CoV-2. |
format | Online Article Text |
id | pubmed-7329657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73296572020-07-02 Laboratory diagnosis of coronavirus disease-2019 (COVID-19) Li, Chenxi Zhao, Chengxue Bao, Jingfeng Tang, Bo Wang, Yunfeng Gu, Bing Clin Chim Acta Review The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of the end of 2020, there were nearly 10 million confirmed cases and nearly 5 million deaths associated with COVID-19. Rapid and early laboratory diagnosis of COVID-19 is the main focus of treatment and control. Molecular tests are the basis for confirmation of COVID-19, but serological tests for SARS-CoV-2 are widely available and play an increasingly important role in understanding the epidemiology of the virus and in identifying populations at higher risk for infection. Point-of-care tests have the advantage of rapid, accurate, portable, low cost and non-specific device requirements, which provide great help for disease diagnosis and detection. This review will discuss the performance of different laboratory diagnostic tests and platforms, as well as suitable clinical samples for testing, and related biosafety protection. This review shall guide for the diagnosis of COVID-19 caused by SARS-CoV-2. Elsevier B.V. 2020-11 2020-07-02 /pmc/articles/PMC7329657/ /pubmed/32621814 http://dx.doi.org/10.1016/j.cca.2020.06.045 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Li, Chenxi Zhao, Chengxue Bao, Jingfeng Tang, Bo Wang, Yunfeng Gu, Bing Laboratory diagnosis of coronavirus disease-2019 (COVID-19) |
title | Laboratory diagnosis of coronavirus disease-2019 (COVID-19) |
title_full | Laboratory diagnosis of coronavirus disease-2019 (COVID-19) |
title_fullStr | Laboratory diagnosis of coronavirus disease-2019 (COVID-19) |
title_full_unstemmed | Laboratory diagnosis of coronavirus disease-2019 (COVID-19) |
title_short | Laboratory diagnosis of coronavirus disease-2019 (COVID-19) |
title_sort | laboratory diagnosis of coronavirus disease-2019 (covid-19) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329657/ https://www.ncbi.nlm.nih.gov/pubmed/32621814 http://dx.doi.org/10.1016/j.cca.2020.06.045 |
work_keys_str_mv | AT lichenxi laboratorydiagnosisofcoronavirusdisease2019covid19 AT zhaochengxue laboratorydiagnosisofcoronavirusdisease2019covid19 AT baojingfeng laboratorydiagnosisofcoronavirusdisease2019covid19 AT tangbo laboratorydiagnosisofcoronavirusdisease2019covid19 AT wangyunfeng laboratorydiagnosisofcoronavirusdisease2019covid19 AT gubing laboratorydiagnosisofcoronavirusdisease2019covid19 |